Spero Therapeutics (SPRO) SPR720 Phase 2a Clinical Trial in NTM-PD Has Been Placed on Clinical Hold by FDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
Go back to Spero Therapeutics (SPRO) SPR720 Phase 2a Clinical Trial in NTM-PD Has Been Placed on Clinical Hold by FDA
February 5, 2021 12:24 PM EST
Spero Therapeutics (NASDAQ: SPRO) Halted on LUDP, Off Lows
...
More
February 5, 2021 8:09 AM EST
Spero Therapeutics (NASDAQ: SPRO) to Resume Trading at 8:30 a.m.
...
More